These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10759957

  • 1. The urokinase plasminogen activator system in angiosarcoma, Kaposi's sarcoma, granuloma pyogenicum, and angioma: an immunohistochemical study.
    Thewes M, Elsner E, Wessner D, Engst R, Ring J.
    Int J Dermatol; 2000 Mar; 39(3):188-91. PubMed ID: 10759957
    [Abstract] [Full Text] [Related]

  • 2. The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer.
    Chambers SK, Gertz RE, Ivins CM, Kacinski BM.
    Cancer; 1995 Apr 01; 75(7):1627-33. PubMed ID: 8826920
    [Abstract] [Full Text] [Related]

  • 3. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
    Costantini V, Sidoni A, Deveglia R, Cazzato OA, Bellezza G, Ferri I, Bucciarelli E, Nenci GG.
    Cancer; 1996 Mar 15; 77(6):1079-88. PubMed ID: 8635127
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients.
    Borstnar S, Vrhovec I, Svetic B, Cufer T.
    Clin Breast Cancer; 2002 Jun 15; 3(2):138-46. PubMed ID: 12123538
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
    Schaefer BM, Stark HJ, Fusenig NE, Todd RF, Kramer MD.
    Exp Cell Res; 1995 Oct 15; 220(2):415-23. PubMed ID: 7556451
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney.
    Xu Y, Hagege J, Mougenot B, Sraer JD, Rønne E, Rondeau E.
    Kidney Int; 1996 Dec 15; 50(6):2011-9. PubMed ID: 8943484
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.
    Heiss MM, Babic R, Allgayer H, Gruetzner KU, Jauch KW, Loehrs U, Schildberg FW.
    J Clin Oncol; 1995 Aug 15; 13(8):2084-93. PubMed ID: 7636552
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
    Bouchet C, Spyratos F, Martin PM, Hacène K, Gentile A, Oglobine J.
    Br J Cancer; 1994 Feb 15; 69(2):398-405. PubMed ID: 8297742
    [Abstract] [Full Text] [Related]

  • 16. Analysis of expressions of components in the plasminogen activator system in high- and low-metastatic human lung cancer cells.
    He C, He P, Liu LP, Zhu YS.
    J Cancer Res Clin Oncol; 2001 Feb 15; 127(3):180-6. PubMed ID: 11260863
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals.
    Herndier BG, Werner A, Arnstein P, Abbey NW, Demartis F, Cohen RL, Shuman MA, Levy JA.
    AIDS; 1994 May 15; 8(5):575-81. PubMed ID: 7520247
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas.
    Fujii T, Obara T, Tanno S, Ura H, Kohgo Y.
    Hepatogastroenterology; 1999 May 15; 46(28):2299-308. PubMed ID: 10521987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.